Delays linked to Hawke's Point? A robust Scoping Study as Rox has repeatedly flagged would attract insto investment. Let's be real: Hawke's Point would know the Study's metrics. IMO Rox hasn't failed to produce a Scoping Study at all. Of course they produced one and it's positive as they said imo Rox has failed to show us retailers the study and technically they don't have to because it's in house finished when they say its finished.. We have been let down but does that really surprise retailers here and ultimately does it matter?
My opinion DYOPR
RXL Price at posting:
24.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)